Workflow
Alcon(ALC)
icon
Search documents
Alcon(ALC) - 2023 Q4 - Annual Report
2024-02-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 ...
Wall Street's Insights Into Key Metrics Ahead of Alcon (ALC) Q4 Earnings
Zacks Investment Research· 2024-02-22 15:20
Analysts on Wall Street project that Alcon (ALC) will announce quarterly earnings of $0.68 per share in its forthcoming report, representing an increase of 61.9% year over year. Revenues are projected to reach $2.34 billion, increasing 8.5% from the same quarter last year.The current level reflects a downward revision of 0.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over ...
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
Businesswire· 2024-01-09 21:30
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced positive topline results from the two pivotal Phase 3 clinical trials (COMET-2 and COMET-3) evaluating the efficacy and safety of AR-15512, a candidate treatment for the signs and symptoms of dry eye disease (DED). In both COMET-2 and COMET-3, which enrolled more than 930 dry eye subjects in total (randomized 1:1 to AR-15512 or vehicle control), the primary endpoint o ...
Alcon(ALC) - 2023 Q3 - Earnings Call Transcript
2023-11-15 16:56
Alcon Inc. (NYSE:ALC) Q3 2023 Earnings Call Transcript November 15, 2023 8:00 AM ET Company Participants Dan Cravens - Vice President and Global Head, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Veronika Dubajova - Citi Larry Biegelsen - Wells Fargo Daniel Buchta - ZKB Ryan Zimmerman - BTIG Anthony Petrone - Mizuho Group Jeff Johnson - Baird Graham Doyle - UBS Operator Greetings and welcome to ...
Alcon(ALC) - 2023 Q3 - Earnings Call Presentation
2023-11-15 13:51
Q3 2023 Earnings Presentation November 15, 2023 Safe harbor Forward-looking statements This document contains, and our officers and representatives may from time to time make, certain “forward-looking statements” within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,” “seek,” “target,” “assume,” “believe,” “projec ...
Alcon(ALC) - 2023 Q2 - Earnings Call Transcript
2023-08-16 15:29
Alcon Inc. (NYSE:ALC) Q2 2023 Earnings Conference Call August 16, 2023 8:00 AM ET Company Participants Daniel Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Veronika Dubajova - Citi Graham Doyle - UBS Ryan Zimmerman - BTIG Daniel Buchta - ZKB Anthony Petrone - Mizuho Group Lawrence Biegelsen - Wells Fargo Brett Fishman - KeyBanc Capital Markets Jeff Johnson - Baird Chris Gretler - Credit Suisse Opera ...
Alcon(ALC) - 2023 Q1 - Earnings Call Transcript
2023-05-10 17:30
Alcon Inc. (NYSE:ALC) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Dan Cravens - VP, IR David Endicott - CEO Tim Stonesifer - CFO Conference Call Participants Anthony Petrone - Mizuho Group Matthew Mishan - KeyBanc Capital Markets Jeff Johnson - Baird Ryan Zimmerman - BTIG Veronica Dubajova - Citi Larry Biegelsen - Wells Fargo David Adlington - JPMorgan Graham Doyle - UBS Steve Lichtman - Oppenheimer Operator Greetings and welcome to the Alcon First Quarter 2023 Earnings Cal ...
Alcon(ALC) - 2022 Q4 - Earnings Call Transcript
2023-02-28 17:54
Alcon Inc. (NYSE:ALC) Q4 2022 Earnings Conference Call February 28, 2023 8:00 AM ET Company Participants Dan Cravens - Vice President & Global Head of Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Graham Doyle - UBS Anthony Petrone - Mizuho Group Larry Biegelsen - Wells Fargo Daniel Buchta - ZKB Matthew Mishan - Keybanc Capital Markets Veronika Dubajova - Citi Cecilia Furlong - Morgan Stanley Ryan Zimmerman - BTIG Chris Gret ...
Alcon(ALC) - 2022 Q4 - Annual Report
2023-02-26 16:00
ALCON INC. INTERIM FINANCIAL REPORT INDEX Page Operating Performance 2 Liquidity and Capital Resources 11 Condensed Consolidated Interim Financial Statements (unaudited) Consolidated Income Statement 15 Consolidated Statement of Comprehensive (Loss)/Income 16 Consolidated Balance Sheet 17 Consolidated Statement of Changes in Equity 18 Consolidated Statement of Cash Flows 19 Notes to Condensed Consolidated Interim Financial Statements 20 Supplementary Information – Definitions and Reconciliations of Non-IFRS ...
Alcon(ALC) - 2022 Q4 - Annual Report
2023-02-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 ...